Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

NCT03864458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia

Interventions

DRUG: KHK7791
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.